![Niamh Alix](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Niamh Alix
Human Resources Officer bij PRIME MEDICINE, INC.
Profiel
Niamh Alix is currently the Chief Human Resources Officer at Prime Medicine, Inc. Prior to this, she worked as the Global VP, Business Partner-HR & Talent at Orchard Therapeutics Plc from 2020 to 2022.
Ms. Alix has a graduate degree from Dublin City University and an undergraduate degree from Technological University Dublin.
Actieve functies van Niamh Alix
Bedrijven | Functie | Begin |
---|---|---|
PRIME MEDICINE, INC. | Human Resources Officer | 01-06-2022 |
Eerdere bekende functies van Niamh Alix
Bedrijven | Functie | Einde |
---|---|---|
ORCHARD THERAPEUTICS PLC | Corporate Officer/Principal | 01-07-2022 |
Opleiding van Niamh Alix
Dublin City University | Graduate Degree |
Technological University Dublin | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PRIME MEDICINE, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Orchard Therapeutics Plc
![]() Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |